Protagonist Therapeutics Inc. (PTGX)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XMEX $
146. 49
-1.26
-0.8528%
$
9.5B Market Cap
- P/E Ratio
- Div Yield
534,120 Volume
0.75 Eps
$ 147.75
Previous Close 
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Protagonist Therapeutics Inc. (PTGX) Statistics
Valuation metrics
Market Cap 9.5B
Enterprise value 8.87B
Trailing P/E (ttm) 118.49
Forward P/E -
PEG ratio -0.14
Price/Sales (ttm) 32.92
Price/Book (mrq) 11.31
Enterprise Value/Revenue 31.46
Enterprise Value/EBITDA 103.78
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 499.78K
Average volume (90 days) 740.26K
Price summary
52-Week low 54.5
52-Week high 160.81
Beta -
50-Day moving average 137.46
200-Day moving average 102.79
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.29%
Operating margin 0.21%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.12%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.28
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.87
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 21.71%
Book value per share (mrq) 12.76
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
